Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2008

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Interventions
DRUG

carboplatin

DRUG

gemcitabine hydrochloride

DRUG

methotrexate

DRUG

vinblastine sulfate

Trial Locations (29)

1000

Institut Jules Bordet, Brussels

1125

National Institute of Oncology, Budapest

2100

Rigshospitalet - Copenhagen University Hospital, Copenhagen

8500

AZ Groeninge - Oncologisch Centrum, Kortrijk

21100

Ospedale di Circolo e Fondazione Macchi, Varese

28040

Hospital Universitario San Carlos, Madrid

46009

Instituto Valenciano De Oncologia, Valencia

70300

Assaf Harofeh Medical Center, Ẕerifin

90145

Universita Di Palermo, Palermo

A-5020

St. Johanns-Spital, Salzburg

A-1100

Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna

B-9300

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

D-90419

Klinikum Nuernberg - Klinikum Nord, Nuremberg

5211 NL

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

1105 AZ

Academisch Medisch Centrum at University of Amsterdam, Amsterdam

2300 CA

Leiden University Medical Center, Leiden

NL-6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

3000 CA

University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam

3584 CX

University Medical Center Utrecht, Utrecht

02-781

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw

08025

Hospital de la Santa Cruz i Sant Pau, Barcelona

08035

Vall d'Hebron University Hospital, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

SO14 0YG

Leeds Cancer Centre at St. James's University Hospital, Southampton

Royal South Hants Hospital, Southampton

SO16 6YD

Southampton General Hospital, Southampton

SM2 5PT

Royal Marsden - Surrey, Sutton

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00014274 - Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | Biotech Hunter | Biotech Hunter